Here are four takeaways:
1. Juan Uribe, MD, Isador Lieberman, MD, Nicholas Renaldo, MD, and Connor Telles, MD, gave hands-on demonstrations and presentations.
2. Michael A. McManus Jr., Misonix president and CEO, said the company’s booth traffic increased by more than 230 percent from 2014.
3. The demonstrations zoned in on the BoneScalpel’s bone cutting and removal function, which reduces bone bleeding and spares soft tissues.
4. Dr. Telles of Sierra Pacific Orthopaedics in Fresno, Calif., said the BoneScalpel “provides more control than traditional instruments and reduces bone bleeding while protecting natural elements.”
More articles on devices:
HSS presents data from 1st US study of CERAMENT void filler for osteomyelitis: 5 observations
SeaSpine creates general counsel position: 5 things to know
Asia to see fastest growth in spinal implants & surgical devices market: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
